Advertisement
Organisation › Details
Genomics plc
Genomics plc was formed in 2014 by four leading scientists at the University of Oxford, including Professor Sir Peter Donnelly (then Director of the Wellcome Centre for Human Genetics) and Professor Gil McVean (then Director of Oxford’s Big Data Institute). Its vision is to use genomic insights to transform drug discovery and precision health. Genomics plc has developed the most powerful engine of its kind in the world linking genetic variation to changes in thousands of human measurements and disease outcomes, together with its own breakthrough machine learning algorithms that use this data at scale to learn directly about human biology. Genomics exploits its core technology and world-leading analytical expertise in two synergistic directions. In drug development, it uses powerful genetic approaches to find novel drug targets and identify the patient groups who will most benefit from them. In precision health, the company is pioneering genomic prevention, the use of genome-wide genetic approaches to understand an individual’s risk for common diseases, deploying these tools in healthcare to change the paradigm to a “prevention first” model. Backed by some of the leading investors in life sciences, Genomics has an expert cross-disciplinary team of 70 people, primarily scientists and software engineers, with offices in Oxford and Cambridge UK. *
Start | 2015-04-13 renamed before | |
Predecessor | Genomics Ltd. | |
Industry | genomic software tools | |
Industry 2 | DNA sequencing technology | |
Person | Colenutt, John (Genomics Ltd 201411 CEO) | |
Person 2 | Donnelly, Peter (Univ Oxford 200411) | |
Region | Oxford, Oxfordshire | |
Country | United Kingdom (GB) | |
Street | Park End Street King Charles House | |
City | OX1 1JD Oxford, Oxfordshire | |
Tel | +44-1865-981-600 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | C: 51 to 100 (2020-03-09) |
* Document for »About Section«: Genomics plc. (3/9/20). "Press Release: Mitchell Harris Joins Genomics plc as Chief Strategy Officer". Oxford. | ||
Record changed: 2023-06-26 |
Advertisement
More documents for Genomics plc
- [1] Genomics plc. (12/10/18). "Press Release: Genomics plc Today Announces Second Close of Its Series B Financing, Raising a further £8 Million, Bringing the Total Round to £33 million ". Oxford....
- [2] Genomics plc. (8/30/18). "Press Release: Genomics plc Raises £25 million in Series B Round to Advance Its Use of Human Genetics and Data Science in Drug Discovery". Oxford....
- [3] Genomics plc. (8/30/18). "Press Release: Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines". Boston, MA & Oxford....
- [4] Genomics plc. (10/16/17). "Press Release: Genomics plc Teams Up with Biogen to Discover New Drug Targets for Multiple Sclerosis". Oxford....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top